1/23
Looks like no tags are added yet.
what signifies mild-moderate UC
4-6 stools/day, minimal symptoms
what type of UC can be treated with enemas
left sided disease
which type of UC can be treated with suppositories
proctitis
how to treat extensive UC disease
requires systemic treatment
first line treatment for mild-mod active UC
oral and/or topical ASAs (combo more effective)
what to do if pt is unresponsive to standard dose 5-ASA
high dose mesalamine plus rectal mesalamine OR budesonide
what is considered mod-severe active UC
4-6 stools per day, +/- blood in stool, some systemic symptoms
induction treatment options
systemic corticosteroids, TNF inhibitors, biologics, newer small molecules
new induction and maintenance options for mod-severe UC
TNF inhibitors, anti-integrin, IL12/23 inhibitors, JAK inhibitors, S1P inhibitors
recommendation for mod-severe active UC if infliximab is used
combination therapy with thiopurine
rule with thiopurine treatment for mod-severe active UC
thiopurine monotherapy should NOT be used for induction, only an option for maintenance
MTX use for treatment of UC
should NOT be used for induction or maintenance
what characterizes severe-fulminant UC
6-10 BMs/day, blood present, systemic symptoms, requires inpatient treatment
what to use in severe UC in patients first and if they are unresponsive
parenteral corticosteroids, consider TNF inhibitors or cyclosporine if pts are unresponsive
maintenance of remission for UC
choice depends on what was used to induce remission
no role for steroids
ASAs, TNF inhibitors, biologic, purines, newer small molecule
recommendation for patients who are on a biologic for remission that failed 5-ASA previously
recommend AGAINST continuing 5-ASA
ASA recommendations for treating mild-mod active CD
sulfasalazine marginally effective, mesalamine derivatives have minimal efficacy and are not recommended
other first line options for mild-mod active CD
controlled release budesonide, diet based strategies
treatment for mod-severe active CD
systemic corticosteroids (maybe IV if hospitalized), early biologic or advanced therapy may be beneficial
can use in mod-severe CD patients who are failing immunosuppressive treatment or steroid dependent pts
TNF inhibitors (infliximab preferred)
what makes TNF inhibitors more effective for CD
combination therapy with AZA or maybe MTX
immunomodulator monotherapy not recommended to induce remission but may help to maintain remission once induced
AZA and 6-MP
drugs that should NOT be used for mod-severe CD
cyclosporine, 5-ASA, sulfasalazine
treatment for severe-fulminant CD
parenteral corticosteroids, infliximab
AZA and 6-MP
MTX
TNF inhibitors
anti-integrin (vedolizumab only)
IL12/23 inhibitors
JAK inhibitor